Cardinal Health (CAH) Leerink Global Healthcare Conference 2026 summary

Business performance and growth drivers

• All five business segments achieved double-digit profit growth in Q2, driven by strong demand, operational excellence, and recent investments.

• Specialty business is a key growth area, expected to surpass $50 billion in revenue this year, with specialty distribution and biopharma services leading the way.

• Recent acquisitions and integration efforts, especially in specialty and at-home care, have contributed to performance and synergy realization.

• The company benefits from demographic trends, with an aging U.S. population driving healthcare demand.

• Investments in innovation, particularly in Nuclear and Precision Health, are positioning the business for future growth.

Specialty and MSO strategy

• Specialty business comprises distribution, MSO assets, and biopharma services, with a focus on diversified, higher-margin revenue streams.

• Integration of technology and analytics platforms, such as Specialty Networks, enhances value for providers and supports real-world evidence generation.

• MSO acquisitions enable scale, operational support, and improved economics for physician practices, especially in urology and oncology.

• The company is open to further organic and inorganic investments to strengthen the specialty portfolio.

• Collaboration with providers focuses on enabling clinical practice while optimizing back-office operations and cost structures.

Contracting, regulatory, and market environment

• Most contracts allow for renegotiation in response to regulatory changes, such as IRA price negotiations, ensuring compensation for services.

• The core distribution business operates on a 1% margin, emphasizing the essential, low-margin nature of pharmaceutical distribution.

• The company expects to manage through commodity price volatility, with limited short-term impact due to contract structures and supply chain improvements.

• Lessons from past disruptions, such as COVID-related freight challenges, have informed current supply chain and contracting strategies.

• The disciplined capital allocation framework prioritizes organic investment, strategic M&A, and shareholder returns.